Biomanufacturing Scale-Up Strategies and Techno-Economic Models

These talk outline various strategic frameworks for biomanufacturing, focusing on how companies can balance capital expenditure against production costs and market speed. The text details four primary models: a CDMO-first approach for rapid entry, modular distributed units for flexibility, large-scale flagship plants for cost leadership, and a hybrid model for balanced risk. Each strategy is evaluated based on its breakeven volume, economic risk, and suitability for different levels of market certainty. Beyond traditional builds, the documents highlight emerging options like retrofitting existing facilities or utilizing continuous fermentation to enhance productivity. Ultimately, the material emphasizes that utilization certainty and capital staging are more critical to profitability than sheer reactor size. The analysis concludes with a specific techno-economic model for producing Brazzein, applying these industrial concepts to a concrete product example.#Bioprocess #ScaleUp and #TechTransfer,#Industrial #Microbiology,#MetabolicEngineering and #SystemsBiology,#Bioprocessing,#MicrobialFermentation,#Bio-manufacturing,#Industrial #Biotechnology,#Fermentation Engineering,#ProcessDevelopment,#Microbiology,#Biochemistry,#Biochemical Engineering, #Applied #MicrobialPhysiology, #Microbial #ProcessEngineering, #Upstream #BioprocessDevelopment, #Downstream Processing and #Purification,#CellCulture and #MicrobialSystems Engineering, #Bioreaction #Enzymes, #Biocatalyst #scientific #Scientist #Research